Equillium (EQ) Cash & Equivalents (2017 - 2026)

Equillium (EQ) has 10 years of Cash & Equivalents data on file, last reported at $60.4 million in Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $60.4 million, up 316.48% year-over-year; the trailing twelve-month figure through Mar 2026 was $60.4 million (up 316.48% YoY), and the FY2025 annual result was $29.7 million, up 64.41% from the prior year.
• Cash & Equivalents grew to $60.4 million in Q1 2026 per EQ's latest filing, from $29.7 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $60.4 million in Q1 2026 and troughed at $11.1 million in Q2 2024.
• A 5-year average of $26.4 million and a median of $24.5 million in 2023 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2022 and 2026: Cash & Equivalents plunged 67.62% in 2022, then soared 316.48% in 2026.
• A 5-year view of Cash & Equivalents shows it stood at $59.1 million in 2022, then plunged by 60.72% to $23.2 million in 2023, then fell by 22.1% to $18.1 million in 2024, then soared by 64.41% to $29.7 million in 2025, then jumped by 103.11% to $60.4 million in 2026.
• Business Quant data shows EQ's Cash & Equivalents at $60.4 million in Q1 2026, $29.7 million in Q4 2025, and $33.1 million in Q3 2025.